Sfoglia per Autore
Viral Reactivation Following COVID-19 Vaccination: a review of the current literature
2024 Martora, Fabrizio; Megna, Matteo; Battista, Teresa; Scalvenzi, Massimiliano; Villani, Alessia; Cacciapuoti, Sara; Potestio, Luca
ChatGPT and Medical Writing in Dermatology: why should we keep writing?
2024 Potestio, Luca; Megna, Matteo; Cacciapuoti, Sara; Martora, Fabrizio; Villani, Alessia
The Past, the Present and the Future of Teledermatology: A Narrative Review
2024 Tommasino, Nello; Megna, Matteo; Cacciapuoti, Sara; Villani, Alessia; Martora, Fabrizio; Ruggiero, Angelo; Genco, Lucia; Potestio, Luca
L-Lysine as an Alternative Treatment for Pityriasis Rosea (PR) [Response to Letter]
2024 Potestio, Luca; Martora, Fabrizio; Cacciapuoti, Sara; Megna, Matteo; Villani, Alessia; Ruggiero, Angelo
Pityriasis Rosea and Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination: A Narrative Review
2024 Potestio, Luca; Martora, Fabrizio; Cacciapuoti, Sara; Megna, Matteo; Villani, Alessia; Ruggiero, Angelo
Herpes Zoster and COVID-19 Vaccination: A Narrative Review
2023 Potestio, Luca; Megna, Matteo; Villani, Alessia; Cacciapuoti, Sara; Scalvenzi, Massimiliano; Martora, Fabrizio
Advancing Dermatology: Embracing the Power of Artificial Intelligence
2023 Potestio, Luca; Martora, Fabrizio; Villani, Alessia; Cacciapuoti, Sara; Battista, Teresa; Megna, Matteo
Reply to: "Usage and perceptions of teledermatology in 2021: a survey of dermatologists" by Ahmad et al
2023 Ruggiero, Angelo; Villani, Alessia; Fabbrocini, Gabriella; Martora, Fabrizio
ChatGPT and Dermatology: friends or foes?
2023 Potestio, Luca; Martora, Fabrizio; Villani, Alessia; Ruggiero, Angelo; Scalvenzi, Massimiliano; Megna, Matteo
Teledermatology for Common Inflammatory Skin Conditions: The Medicine of the Future?
2023 Martora, Fabrizio; Fabbrocini, Gabriella; Megna, Matteo; Scalvenzi, Massimiliano; Battista, Teresa; Villani, Alessia; Potestio, Luca
Development of a Patient-Reported Outcome Measure (PROM) for Dysgeusia During Treatment With Smoothened (SMO) Inhibitors for Basal Cell Carcinomas: The SMO-iD Questionnaire
2023 Camela, Elisa; Villani, Alessia; Ocampo Garza, Sonia Sofia; Costa, Claudia; Fabbrocini, Gabriella; Megna, Matteo; Potestio, Luca; Ruggiero, Angelo; Scalvenzi, Massimiliano
Advanced Squamous Cell Carcinoma Developed on Chronic Hidradenitis Suppurativa, Successfully Treated with Cemiplimab: A Case Report
2023 Ruggiero, Angelo; Lauro, Wanda; Miano, Chiara; Villani, Alessia; Fabbrocini, Gabriella; Marasca, Claudio
A case of multiple basal cell carcinomas in an immunocompromised skin district: The aetiopathogenetic role of congenital lymphqedema
2023 Picone, Vincenzo; Villani, Alessia; Feo, Federica; Fabbrocini, Gabriella
Comment on 'Development of Chilblains Lesions During the COVID-19 Pandemic is Strongly Associated with Cold Weather: Retrospective Analysis of Patients from a Single Center in the United States'
2023 Potestio, Luca; Martora, Fabrizio; Megna, Matteo; Villani, Alessia; Cacciapuoti, Sara
Cutaneous adverse reaction following COVID-19 vaccination: Report from a southern Italian referral centre. Comment on "cutaneous adverse reactions following the Pfizer/BioNTech COVID-19 vaccine" by Luo et al
2023 Martora, Fabrizio; Villani, Alessia; Marasca, Claudio; Fabbrocini, Gabriella; Ruggiero, Angelo
Comment on: “Clinical characteristics of patients with pityriasis rubra pilaris following SARS‐CoV‐2 vaccination” by Gambichler
2023 Potestio, Luca; Martora, Fabrizio; Villani, Alessia; Megna, Matteo; Ruggiero, Angelo
Letter to the editor regarding article "Falotico JM, Gu L, Lipner SR. Not just pimple popping: The utility of hybrid telemedicine models beyond acne management amidst the ongoing COVID-19 pandemic. J Cosmet Dermatol. 2022;10.1111/jocd.15256"
2023 Potestio, Luca; Villani, Alessia; Raia, Flavia; Fabbrocini, Gabriella; Martora, Fabrizio
Bimekizumab treatment in patients with moderate to severe plaque psoriasis: a drug safety evaluation
2023 Ruggiero, Angelo; Potestio, Luca; Martora, Fabrizio; Villani, Alessia; Comune, Rosita; Megna, Matteo
Reply to ‘Impact of the French COVID ‐19 pandemic lockdown on newly diagnosed melanoma delay and severity’ by R. Molinier et al
2023 Ruggiero, Angelo; Martora, Fabrizio; Fornaro, Fabrizio; Scalvenzi, Massimiliano; Fabbrocini, Gabriella; Villani, Alessia
Skin reaction after SARS-CoV-2 vaccines Reply to 'cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: A real-life multicentre experience'
2023 Martora, Fabrizio; Villani, Alessia; Marasca, Claudio; Fabbrocini, Gabriella; Potestio, Luca
Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
---|---|---|---|---|
Viral Reactivation Following COVID-19 Vaccination: a review of the current literature | 1.8 Articolo in rassegna (review) | 2024 | Martora, Fabrizio; Megna, Matteo; Battista, Teresa; Scalvenzi, Massimiliano; Villani, Alessia; Cacciapuoti, Sara; Potestio, Luca | |
ChatGPT and Medical Writing in Dermatology: why should we keep writing? | 1.1 Articolo in rivista | 2024 | Potestio, Luca; Megna, Matteo; Cacciapuoti, Sara; Martora, Fabrizio; Villani, Alessia | |
The Past, the Present and the Future of Teledermatology: A Narrative Review | 1.1 Articolo in rivista | 2024 | Tommasino, Nello; Megna, Matteo; Cacciapuoti, Sara; Villani, Alessia; Martora, Fabrizio; Ruggiero, Angelo; Genco, Lucia; Potestio, Luca | |
L-Lysine as an Alternative Treatment for Pityriasis Rosea (PR) [Response to Letter] | 1.1 Articolo in rivista | 2024 | Potestio, Luca; Martora, Fabrizio; Cacciapuoti, Sara; Megna, Matteo; Villani, Alessia; Ruggiero, Angelo | |
Pityriasis Rosea and Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination: A Narrative Review | 1.8 Articolo in rassegna (review) | 2024 | Potestio, Luca; Martora, Fabrizio; Cacciapuoti, Sara; Megna, Matteo; Villani, Alessia; Ruggiero, Angelo | |
Herpes Zoster and COVID-19 Vaccination: A Narrative Review | 1.8 Articolo in rassegna (review) | 2023 | Potestio, Luca; Megna, Matteo; Villani, Alessia; Cacciapuoti, Sara; Scalvenzi, Massimiliano; Martora, Fabrizio | |
Advancing Dermatology: Embracing the Power of Artificial Intelligence | 1.1 Articolo in rivista | 2023 | Potestio, Luca; Martora, Fabrizio; Villani, Alessia; Cacciapuoti, Sara; Battista, Teresa; Megna, Matteo | |
Reply to: "Usage and perceptions of teledermatology in 2021: a survey of dermatologists" by Ahmad et al | 1.7 Commento, erratum, replica e simili | 2023 | Ruggiero, Angelo; Villani, Alessia; Fabbrocini, Gabriella; Martora, Fabrizio | |
ChatGPT and Dermatology: friends or foes? | 1.1 Articolo in rivista | 2023 | Potestio, Luca; Martora, Fabrizio; Villani, Alessia; Ruggiero, Angelo; Scalvenzi, Massimiliano; Megna, Matteo | |
Teledermatology for Common Inflammatory Skin Conditions: The Medicine of the Future? | 1.1 Articolo in rivista | 2023 | Martora, Fabrizio; Fabbrocini, Gabriella; Megna, Matteo; Scalvenzi, Massimiliano; Battista, Teresa; Villani, Alessia; Potestio, Luca | |
Development of a Patient-Reported Outcome Measure (PROM) for Dysgeusia During Treatment With Smoothened (SMO) Inhibitors for Basal Cell Carcinomas: The SMO-iD Questionnaire | 1.1 Articolo in rivista | 2023 | Camela, Elisa; Villani, Alessia; Ocampo Garza, Sonia Sofia; Costa, Claudia; Fabbrocini, Gabriella; Megna, Matteo; Potestio, Luca; Ruggiero, Angelo; Scalvenzi, Massimiliano | |
Advanced Squamous Cell Carcinoma Developed on Chronic Hidradenitis Suppurativa, Successfully Treated with Cemiplimab: A Case Report | 1.1 Articolo in rivista | 2023 | Ruggiero, Angelo; Lauro, Wanda; Miano, Chiara; Villani, Alessia; Fabbrocini, Gabriella; Marasca, Claudio | |
A case of multiple basal cell carcinomas in an immunocompromised skin district: The aetiopathogenetic role of congenital lymphqedema | 1.1 Articolo in rivista | 2023 | Picone, Vincenzo; Villani, Alessia; Feo, Federica; Fabbrocini, Gabriella | |
Comment on 'Development of Chilblains Lesions During the COVID-19 Pandemic is Strongly Associated with Cold Weather: Retrospective Analysis of Patients from a Single Center in the United States' | 1.1 Articolo in rivista | 2023 | Potestio, Luca; Martora, Fabrizio; Megna, Matteo; Villani, Alessia; Cacciapuoti, Sara | |
Cutaneous adverse reaction following COVID-19 vaccination: Report from a southern Italian referral centre. Comment on "cutaneous adverse reactions following the Pfizer/BioNTech COVID-19 vaccine" by Luo et al | 1.1 Articolo in rivista | 2023 | Martora, Fabrizio; Villani, Alessia; Marasca, Claudio; Fabbrocini, Gabriella; Ruggiero, Angelo | |
Comment on: “Clinical characteristics of patients with pityriasis rubra pilaris following SARS‐CoV‐2 vaccination” by Gambichler | 1.1 Articolo in rivista | 2023 | Potestio, Luca; Martora, Fabrizio; Villani, Alessia; Megna, Matteo; Ruggiero, Angelo | |
Letter to the editor regarding article "Falotico JM, Gu L, Lipner SR. Not just pimple popping: The utility of hybrid telemedicine models beyond acne management amidst the ongoing COVID-19 pandemic. J Cosmet Dermatol. 2022;10.1111/jocd.15256" | 1.1 Articolo in rivista | 2023 | Potestio, Luca; Villani, Alessia; Raia, Flavia; Fabbrocini, Gabriella; Martora, Fabrizio | |
Bimekizumab treatment in patients with moderate to severe plaque psoriasis: a drug safety evaluation | 1.1 Articolo in rivista | 2023 | Ruggiero, Angelo; Potestio, Luca; Martora, Fabrizio; Villani, Alessia; Comune, Rosita; Megna, Matteo | |
Reply to ‘Impact of the French COVID ‐19 pandemic lockdown on newly diagnosed melanoma delay and severity’ by R. Molinier et al | 1.7 Commento, erratum, replica e simili | 2023 | Ruggiero, Angelo; Martora, Fabrizio; Fornaro, Fabrizio; Scalvenzi, Massimiliano; Fabbrocini, Gabriella; Villani, Alessia | |
Skin reaction after SARS-CoV-2 vaccines Reply to 'cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: A real-life multicentre experience' | 1.7 Commento, erratum, replica e simili | 2023 | Martora, Fabrizio; Villani, Alessia; Marasca, Claudio; Fabbrocini, Gabriella; Potestio, Luca |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile